STU 3 Ballot
MedicationsThis page is part of the FHIR Specification (v1.6.0: STU 3 Ballot 4). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
Order for Intravenous Chemotherapy (inpatient order) - Alemtuzumab - completed with multiple dosageInstruction lines
{
"resourceType": "MedicationOrder",
"id": "medrx0317",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: medrx0317</p><p><b>contained</b>: </p><p><b>identifier</b>: 12345689 (OFFICIAL)</p><p><b>status</b>: completed</p><p><b>medication</b>: id: med0303; Alemtuzumab 10mg/ml (Lemtrada) <span>(Details : {RxNorm code '1594660' = '??', given as 'Alemtuzumab 10mg/ml (Lemtrada)'})</span></p><p><b>patient</b>: <a>Donald Duck</a></p><p><b>dateWritten</b>: 15/01/2015</p><p><b>prescriber</b>: <a>Patrick Pump</a></p><p><b>reasonCode</b>: Chronic Lymphoid Leukemia (disorder) <span>(Details : {SNOMED CT code '92814006' = 'Chronic lymphoid leukaemia, disease', given as 'Chronic Lymphoid Leukemia (disorder)'})</span></p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p><p><b>additionalInstructions</b>: Rapidly increase dose until tolerated <span>(Details )</span>, Administer on alternate days <span>(Details )</span></p><p><b>timing</b>: Duration 12weeks, Do 3 per 1 weeks</p><p><b>route</b>: Intravenous route (qualifier value) <span>(Details : {SNOMED CT code '47625008' = 'Intravenous route (qualifier value)', given as 'Intravenous route (qualifier value)'})</span></p><p><b>method</b>: Inject - dosing instruction imperative (qualifier value) <span>(Details : {SNOMED CT code '422145002' = 'Inject - dosing instruction imperative (qualifier value)', given as 'Inject - dosing instruction imperative (qualifier value)'})</span></p><p><b>dose</b>: 3 mg<span> (Details: LOINC code mg = '??')</span></p></blockquote><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p><p><b>additionalInstructions</b>: Rapidly increase dose until tolerated <span>(Details )</span>, Administer on alternate days <span>(Details )</span></p><p><b>timing</b>: Duration 12weeks, Do 3 per 1 weeks</p><p><b>route</b>: Intravenous route (qualifier value) <span>(Details : {SNOMED CT code '47625008' = 'Intravenous route (qualifier value)', given as 'Intravenous route (qualifier value)'})</span></p><p><b>method</b>: Inject - dosing instruction imperative (qualifier value) <span>(Details : {SNOMED CT code '422145002' = 'Inject - dosing instruction imperative (qualifier value)', given as 'Inject - dosing instruction imperative (qualifier value)'})</span></p><p><b>dose</b>: 10 mg<span> (Details: LOINC code mg = '??')</span></p></blockquote><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p><p><b>additionalInstructions</b>: Rapidly increase dose until tolerated <span>(Details )</span>, Administer on alternate days <span>(Details )</span></p><p><b>timing</b>: Duration 12weeks, Do 3 per 1 weeks</p><p><b>route</b>: Intravenous route (qualifier value) <span>(Details : {SNOMED CT code '47625008' = 'Intravenous route (qualifier value)', given as 'Intravenous route (qualifier value)'})</span></p><p><b>method</b>: Inject - dosing instruction imperative (qualifier value) <span>(Details : {SNOMED CT code '422145002' = 'Inject - dosing instruction imperative (qualifier value)', given as 'Inject - dosing instruction imperative (qualifier value)'})</span></p><p><b>dose</b>: 30 mg<span> (Details: LOINC code mg = '??')</span></p></blockquote></div>"
},
"contained": [
{
"resourceType": "Medication",
"id": "med0303",
"code": {
"coding": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"code": "1594660",
"display": "Alemtuzumab 10mg/ml (Lemtrada)"
}
]
}
}
],
"identifier": [
{
"use": "official",
"system": "http://www.bmc.nl/portal/prescriptions",
"value": "12345689"
}
],
"status": "completed",
"medicationReference": {
"reference": "#med0303"
},
"patient": {
"reference": "Patient/pat1",
"display": "Donald Duck"
},
"dateWritten": "2015-01-15",
"prescriber": {
"reference": "Practitioner/f007",
"display": "Patrick Pump"
},
"reasonCode": [
{
"coding": [
{
"system": "http://snomed.info/sct",
"code": "92814006",
"display": "Chronic Lymphoid Leukemia (disorder)"
}
]
}
],
"dosageInstruction": [
{
"text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstructions": [
{
"text": "Rapidly increase dose until tolerated"
},
{
"text": "Administer on alternate days"
}
],
"timing": {
"repeat": {
"duration": 12,
"durationUnit": "wk",
"frequency": 3,
"period": 1,
"periodUnit": "wk"
}
},
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "47625008",
"display": "Intravenous route (qualifier value)"
}
]
},
"method": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "422145002",
"display": "Inject - dosing instruction imperative (qualifier value)"
}
]
},
"doseQuantity": {
"value": 3,
"unit": "mg",
"system": "http://loinc.org",
"code": "mg"
}
},
{
"text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstructions": [
{
"text": "Rapidly increase dose until tolerated"
},
{
"text": "Administer on alternate days"
}
],
"timing": {
"repeat": {
"duration": 12,
"durationUnit": "wk",
"frequency": 3,
"period": 1,
"periodUnit": "wk"
}
},
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "47625008",
"display": "Intravenous route (qualifier value)"
}
]
},
"method": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "422145002",
"display": "Inject - dosing instruction imperative (qualifier value)"
}
]
},
"doseQuantity": {
"value": 10,
"unit": "mg",
"system": "http://loinc.org",
"code": "mg"
}
},
{
"text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstructions": [
{
"text": "Rapidly increase dose until tolerated"
},
{
"text": "Administer on alternate days"
}
],
"timing": {
"repeat": {
"duration": 12,
"durationUnit": "wk",
"frequency": 3,
"period": 1,
"periodUnit": "wk"
}
},
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "47625008",
"display": "Intravenous route (qualifier value)"
}
]
},
"method": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "422145002",
"display": "Inject - dosing instruction imperative (qualifier value)"
}
]
},
"doseQuantity": {
"value": 30,
"unit": "mg",
"system": "http://loinc.org",
"code": "mg"
}
}
]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
© HL7.org 2011+. FHIR STU3 Ballot (v1.6.0-9663) generated on Thu, Aug 11, 2016 17:06+1000. QA Page
Links: Search |
Version History |
Table of Contents |
Compare to DSTU2 |
|
Propose a change